论文部分内容阅读
目的:观察香丹注射液静脉滴注联合低分子肝素皮下注射治疗不稳定心绞痛的临床疗效。方法:将160例不稳定型心绞痛患者随机分为2组各80例,对照组予以常规西药治疗;治疗组在常规治疗的基础上加用香丹注射液联合低分子肝素皮下注射,观察治疗前后心绞痛症状和心电图表现。结果:总有效率治疗组为93.8%,对照组为71.3%,2组比较,差异有非常显著性意义(P<0.01)。ST下降总量、T波倒置总深度2组治疗后与治疗前比较,差异均有非常显著性意义(P<0.01),2组治疗后比较,差异有非常显著性意义(P<0.01)。结论:香丹注射液静脉滴注联合低分子肝素皮下注射治疗不稳定心绞痛临床疗效及心电图的主要指标均有显著的改善。
Objective: To observe the clinical efficacy of Xiangdan injection combined with low molecular weight heparin subcutaneous injection in the treatment of unstable angina pectoris. Methods: 160 patients with unstable angina pectoris were randomly divided into two groups of 80 cases, the control group to be treated with conventional Western medicine; the treatment group on the basis of routine treatment plus Xiangdan injection combined with low molecular weight heparin subcutaneous injection before and after treatment Angina symptoms and electrocardiogram performance. Results: The total effective rate was 93.8% in the treatment group and 71.3% in the control group. There was significant difference between the two groups (P <0.01). The total amount of ST decreased and the total depth of T wave inversion were significantly different between the two groups after treatment and before treatment (P <0.01). There was significant difference between the two groups after treatment (P <0.01). Conclusion: Xiangdan injection combined with low molecular weight heparin subcutaneous injection of unstable angina pectoris clinical efficacy and the main indicators of ECG were significantly improved.